KAPA Financials

Kairos Pharma Ltd - Financial statements & key metrics

Stock Price

$0.61

Market Cap

$13.10M

EPS

$-0.30

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-2.60M

EPS (Diluted)

$-0.23

Balance Sheet Highlights

Total Assets

$5.77M

Total Liabilities

$992,000

Shareholders Equity

Cash & Equivalents

$1.27M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-3.96M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-1.0%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KAPA revenue?

View KAPA's income statement for detailed revenue data.

Is KAPA profitable?

KAPA reported a loss of $2.60M in the most recent quarter.

What is KAPA market cap?

KAPA has a market capitalization of $13.10M, making it a small-cap stock.

Does KAPA have debt?

View KAPA's balance sheet for debt information.

What is KAPA cash flow?

Cash flow data is available in the full financial statements.